drugset / Trial / NCT02296762
Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to assess the Sirolimus Tablets 2 mg of Dr. Reddy's Laboratories Limited, India and Rapamune® (Sirolimus) tablets 2 mg of Wyeth Laboratories, Philadelphia in healthy, adult,human subjects under Fed conditions.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 2 mg | Oral |
Indications
No indication recorded.